The American Journal of Managed Care

What’s Next for Systemic Therapy in CSCC?

The future of systemic therapy for cutaneous squamous cell carcinoma (CSCC) is rapidly evolving, with research focused on ...
Medscape

SBRT Delays Systemic Therapy in Oligometastatic Cancers

Stereotactic body radiotherapy (SBRT) alone achieves a 69.7% pooled 1- or 2-year systemic therapy-free survival rate across cancer types, with the highest rates seen in renal cell and prostate cancers ...
The American Journal of Managed Care

Oncology Care Model Tied to Reduced Chemotherapy, Lower Medicare Spending in Poor-Prognosis Cancers

The CMS Oncology Care Model (OCM) was associated with reduced chemotherapy initiation and lower Medicare spending among ...

Evidence-Based Psychotherapy Models Expand As Consumers Seek Specialist Treatment Approaches

This growth has been accompanied by increasing consumer sophistication in identifying and requesting specific therapeutic modalities, moving beyond generic counselling toward structured psychotherapy ...